Toxicity of Resin 3D Printing Emissions Phase 1 Tender - 142326153

Procurement Summary

Country: USA

Summary: Toxicity of Resin 3D Printing Emissions Phase 1

Deadline: 13 Jun 2026

Posting Date: 30 May 2026

Other Information

Notice Type: Tender

TOT Ref.No.: 142326153

Document Ref. No.: 98148

Competition: ICB

Financier: Self Financed

Purchaser Ownership: Public

Tender Value: Refer Document

Purchaser's Detail

Name: Login to see tender_details

Address: Login to see tender_details

Email: Login to see tender_detailsLogin to see details

Tender Details

The Centers for Disease Control and Prevention intends to award a sole source firm fixed price purchase order to Department of Orthopaedics, School of Medicine West Virginia University (WVU). for Procurement of the measurement of toxicity associated with resin 3-D printing emissions. Resin 3-D printing, also known as vat photopolymerization (VP) will be evaluated. Specifically, the vendor shall: a) determine the dose-response relationship of pulmonary inflammation and systemic toxicity induced by VP printing emissions in mice and b) determine the sensitization potential following inhalation exposure to VP printing emissions in mice. Dr. Li-s research at the School of Medicine, West Virginia University (WVU), focuses on nanoparticle toxicity, immunotherapy, nanomedicine, advanced materials, and biomedical engineering. He has been well funded by NIH and other federal agencies and has recently collaborated with NIOSH scientists. This procurement research project aligns closely with his expertise. The WVU School of Medicine campus is adjacent to the NIOSH Morgantown campus which is a critical fact that supports sole source procurement. The proposed inhalation toxicology studies require 1) unique training, 2) unique exposure system, and 3) rapid transfer of samples with limited stability to NIOSH Morgantown. Specifically, NIOSH staff will need to provide the vendor with training on how to perform some experimental steps via in-person training. It is not feasible for NIOSH staff to travel to perform this training for a vendor outside the local area. A NIOSH designed and built exposure generation system is required to perform the experiments. The size, weight, and intricate properties of this system prevent it from being shipped so a local vendor must be used to permit transfer of the equipment for the study period. Additionally, the specialized exposure generation system can require frequent coordination, monitoring, and, when necessary, immediate technical adjustments by...
Notice ID: 98148

Department/Ind. Agency: health and human services, department of

Sub-tier: centers for disease control and prevention

Office: cdc office of acquisition services

Product Service Code: aj11 - general science and technology r&d services; general science and technology; basic research

NAICS Code: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)

Inactive Dates: jun 13, 2026

Inactive Policy: manual

Documents

 Tender Notice